Pfizer, Lilly Drugs Show Promise in Slowing Breast Cancer

Two drugs from Pfizer and Eli Lilly that employ a new therapeutic approach showed promise in slowing the course of breast cancer, according to early-stage research released on Sunday.

Leave a Reply

Your email address will not be published. Required fields are marked *